new million dollar grant

I know I keep extolling the virtues of this company but if you are looking for a longer-term biotech investment, You really should take a look at this company.



Anadis & TMI win $1 million Government Grant for immunity stimulating
infant formula
Anadis Ltd (ASX: ANX) together with Tatura Milk Industries (TMI) are pleased
to announce the winning of a research grant for approximately one million
dollars. This Commonwealth Government Food Innovation Grant (“FIG” grant)
is for research aimed at developing a specialty milk powder for human infant
formula. This new product will contain naturally high levels of anti-oxidants -
which appears to be important in the immune development of children. The
new product is part of the Anadis Tatura Innovation Engine Room (ATIER)
development pipeline which is aimed at creating high value dairy products.
The rewards from the sale of this product will be shared by Anadis and TMI.
The Anadis / TMI project is based on the development of a health enhanced
infant and child formula product for Asia.
Infants are born with poorly developed immune systems, and immune health
is more significant in Asia than in the West because of enhanced risks from
diseases such as viral and bacterial gastroenteritis, respiratory diseases and
Enterovirus 71 (a polio-like virus) which has recently emerged in Taiwan and
China.
The total market size is approximately 290,000 metric tonnes with a wholesale
value of AUD $1.6 Billion, growing at an average of 5% per year. By volume:
China 52%, Indonesia 16%, Japan 12%, South Korea 10% and Taiwan 10%.
If successful, the Anadis / TMI team expect significant interest from
consumers for this product.
Expected benefits of this formula include:
• Enhanced immune protection for infants
arising from the capacity of antioxidants to
stimulate immune function.
• Safe and effective function based on
matching the anti-oxidant function levels
found in human breast milk.
• Strong natural pathways for enhancing the
anti-oxidant content. This is extremely
favourable around the world and especially in
Asia.
• Evidence of health benefits for the cow
arising from the speciality diet. The inference
is that healthier cows will provide more
healthy milk.
One of the major differences in this project, from the usual approach of adding
artificial forms of bio-actives to infant formula, is that the Anadis / TMI product
is made naturally i.e, the cow includes the antioxidant in the milk - packaged
much the same way it is in human mothers’ milk.
There is already advanced interest from Asian distributors for this product.
A natural pathways approach is being developed for introducing the
antioxidant into cow’s milk and thereby into whole milk based infant and child
formulas. The challenge exists to achieve breast-milk equivalent bioavailability
and bioactivity of the antioxidant. This research project, up to pilot scale work,
is to run for 2 years.
This funding gives an enormous vote of confidence to product development
initiatives under the ATIER committee - a research committee to co-develop
new food products for Australia and overseas, particularly focused on
Functional Foods and Nutraceuticals.